I’m going to give you the benefit of the doubt. Here is my understanding:
1) The way that NHS reimbursement works in the UK is that you have to but it from the pharmacist counter to have it covered. So BIEL decided to pull it from the OTC shelves themselves. Now they are focusing on educating doctors and pharmacists. You can still buy it “OTC” on Amazon UK or whatever (it is legal to do so), but you won’t get NHS coverage if you do so. So yes, there was/is a drop in U.K.sales which should be temporary until the pharmacist/doctor angle gets going.
2) The regional issue I believe is a manufactured non-issue that Red cobbled together from unrelated sources with no context. He found some Leicestershire (not sure if that’s the right spelling/name) webpage which said something about a “review” of Actipatch in 2021. Red doesn’t know what that means and no one else does either so I’m ignoring it. For all we know that could be a re-review so that it can stay covered. As far as I’m concerned, because the NHS publicly approved it, it’s available in all the Shires, or will be after stocking/shipping, including in Barrowtown and Rivendell.
3) I wouldn’t worry about “share dumping” that word has been a bit of a scare tactic for years we don’t know how much the settlement is for. My personal opinion is that they wouldn’t fund it that way. Big players (cvs and Bayer just to name two) are interested in this and any amount (even the original amount) is chump change. Why wouldn’t they pay that for BIEL in exchange for slightly more favorable deal terms? Like Suge paying Pac’s bail money.
*Don’t get to put off by the board, people get territorial around here after years of obsessively watching this.
News 
Market Data 
Discover 
AI
